David Plank, MD
Plastic and Reconstructive Surgery · Orlando, FLNPI 1689838559
Payments from drug & device makers
Across 14 payments — averaging $178.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Integra Lifesciences Corporation$143
- Cumberland Pharmaceuticals, Inc.$100
- Smith+Nephew$86
- Revance Therapeutics, Inc.$54
- Pacira Pharmaceuticals Incorporated$21
- plus $14 from 1 others
What the payments were for
- Food & beverage$45118%
- Gifts$2,05482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 4 | $2,087 |
| Integra Lifesciences Corporation | 2 | $143 |
| Cumberland Pharmaceuticals, Inc. | 1 | $100 |
| Smith+Nephew | 4 | $86 |
| Revance Therapeutics, Inc. | 1 | $54 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$2,054
- BILAYER WOUND MATRIX (BWM)$118
- INTEGRA WOUND MATRIX (IWM)$118
- AMNIOEXCEL$118
- IDRT$118
- FLOWABLE$118
- Caldolor$100
How this compares
$2,505 in reported general payments places this provider in the 40th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 15 | $775 |
| Imiquimod | 17 | $326 |
| Amoxicillin | 40 | $133 |
| Tramadol Hcl | 17 | $102 |
| Clindamycin Hcl | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Orlando
- John ChoiOrlando$45K
- Kenneth LeeOrlando$42K
- Adam OppenheimerOrlando$38K
- Omar BeidasOrlando$29K
- Vincent ChavanonOrlando$21K
- Sabrina PavriOrlando$16K
- Michael McClureOrlando$15K
- George PopeOrlando$14K
- Luis AponteTampa$840K
- Alan DurkinVero Beach$549K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.